BERKELEY, CA – August 30, 2016 – Caribou Biosciences, Inc., a developer of CRISPR-Cas technologies for genome engineering, announced today that Vonnie Estes has joined the Company as Group Leader, Agricultural and Industrial Biotechnology. Ms. Estes brings decades of experience across the agriculture and industrial biotech industries and will lead the Company’s partnership and business development activities in these sectors.

BERKELEY, Calif. -- May 18, 2016 -- Genus plc (LSE: GNS) (“Genus”), a global pioneer in animal genetics, and Caribou Biosciences, Inc. (“Caribou”), a leader in the revolutionary field of CRISPR-Cas gene editing, are pleased to announce a multi-year strategic collaboration where Genus receives a worldwide, exclusive license to Caribou’s leading CRISPR-Cas9 gene editing technology platform in certain livestock species. This is a significant move for Genus and marks the largest technology-driven alliance that Genus has made to date.